To clarify whether SPARC had a differential involvement in the various phases of breast carcinoma progression, we evaluated SPARC expression in dysplastic lesions, primary ductal carcinoma and bone metastasis using human specimens pair-matched (n = 5). This evidence concerns the gene SPARC and breast carcinoma.